Considering that IL-1β levels are statistically higher in PSP-P than in PSP-RS, and the cognitive function deterioration is more pronounced in PSP-RS, it therefore supports the hypothesis of the protective effect of IL-1β. The gene discussed is IL1B; the disease is supranuclear palsy, progressive, 1.